Approval · Notice of Compliance 35697 · 2025
TEZSPIRE: Notice of Compliance 35697
Issued July 18, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35697
- Date
- July 18, 2025
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEZSPIRE | Not yet assigned | — |
Medicinal ingredients
- TEZEPELUMAB 110 MG per ML